ETTYF Stock Chart & Stats
$27.78
-$1.35(-5.13%)
At close: 4:00 PM EST
$27.78
-$1.35(-5.13%)
Day’s Range― - ―
52-Week Range$23.78 - $32.97
Previous CloseN/A
Volume2.06K
Average Volume (3M)45.00
Market Cap
$19.41B
Enterprise Value$214.49B
Total Cash (Recent Filing)$12.12B
Total Debt (Recent Filing)$42.31B
Price to Earnings (P/E)15.4
Beta0.13
Next Earnings
Jul 16, 2026EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend Yield2.6%
Share Statistics
EPS (TTM)18.17
Shares Outstanding625,744,500
10 Day Avg. Volume137
30 Day Avg. Volume45
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.13
Price to Sales (P/S)1.32
P/FCF Ratio21.83
Enterprise Value/Market Cap11.05
Enterprise Value/Revenue1.57
Enterprise Value/Gross Profit4.69
Enterprise Value/Ebitda8.36
Forecast
1Y Price Target
$25.54Price Target Upside-8.06% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)1.96
Revenue Forecast (FY)$14.44B
Bulls Say, Bears Say
Bulls Say
Balance Sheet De‑leveragingMaterial reduction in leverage and net debt positions strengthens financial flexibility, lowers interest burden and supports capital allocation choices (M&A, buybacks, dividends). With net debt/EBITDA near ~1.0 management can fund strategic moves or absorb shocks without jeopardizing investment capacity.
Sustained Margin RecoveryHigher gross and net margins indicate structural improvements in pricing, mix and cost control versus earlier years. This margin base supports durable cash generation and ROE (~15%), providing a buffer versus cyclical input swings and funding for reinvestment and shareholder returns over the medium term.
Scale Via Strategic M&AAcquiring established brands (OB, Playtex, Carefree, Stayfree) immediately increases U.S. scale and category breadth, enabling cross-sell, procurement leverage and R&D synergies. If integration and brand migration succeed, the deal enhances long-term growth runway in a large, higher-margin market.
Bears Say
Top-line SofteningPersistent weak or flat top-line growth limits operating leverage and the ability to expand earnings sustainably. With revenue drifting, the company must rely more on margin actions and cost programs to drive profit, increasing execution risk and constraining medium-term organic growth prospects.
Consumer Tissue Weakness (Europe)European tissue softness affects a core category with steady consumption; negative price/mix and volume declines directly pressure gross profit and cash flow. Given tissue's scale in the portfolio, sustained weakness would erode group margins and require reallocation of marketing or pricing resources to defend share.
Input-cost Inflation & Hedging GapsSignificant exposure to pulp, plastics and energy with partial hedges creates earnings volatility as costs hit the P&L before pricing actions take effect. This lag and limited hedging increase the risk of margin erosion in the near-to-medium term and require disciplined pricing and supply-chain responses.
Essity AB News
ETTYF FAQ
What was Essity AB’s price range in the past 12 months?
Essity AB lowest stock price was $23.78 and its highest was $32.97 in the past 12 months.
What is Essity AB’s market cap?
Essity AB’s market cap is $19.41B.
When is Essity AB’s upcoming earnings report date?
Essity AB’s upcoming earnings report date is Jul 16, 2026 which is in 2 days.
How were Essity AB’s earnings last quarter?
Essity AB released its earnings results on Apr 23, 2026. The company reported $0.436 earnings per share for the quarter, missing the consensus estimate of $0.437 by -$0.001.
Is Essity AB overvalued?
According to Wall Street analysts Essity AB’s price is currently Overvalued.
Does Essity AB pay dividends?
Essity AB pays a Annually dividend of $0.916 which represents an annual dividend yield of 2.6%. See more information on Essity AB dividends here
What is Essity AB’s EPS estimate?
Essity AB’s EPS estimate is 0.45.
How many shares outstanding does Essity AB have?
Essity AB has 625,744,500 shares outstanding.
What happened to Essity AB’s price movement after its last earnings report?
Essity AB reported an EPS of $0.436 in its last earnings report, missing expectations of $0.437. Following the earnings report the stock price went down -0.651%.
Which hedge fund is a major shareholder of Essity AB?
Currently, no hedge funds are holding shares in ETTYF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Essity AB
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
ETTYF Net sales Breakdown
54.31% Consumer Goods
26.83% Professional Hygiene
18.84% Health & Medical
0.02% Other
ETTYF Stock 12 Month Forecast
Average Price Target
$25.54
▼(-8.06% Downside)
Technical Analysis
Ownership Overview
―
Insiders
6.64% Mutual Funds
0.20% Other Institutional Investors
82.16% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---